Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Hibiscus wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
2 of 2 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Hibiscus and Sage have evidence — compare verdict strength side-by-side.
250–450 mg standardized extract OR 1.25–2.5 g dried calyx per serving (as tea)
With meals, 2–3 times daily, Morning and afternoon preferred
Standardized extract capsule (anthocyanins ≥10%)
300–600 mg standardized extract daily
With breakfast, With dinner (split dosing)
Standardized extract (300–600 mg, 2.5% rosmarinic acid)
4–6 weeks
6–8 weeks
Acute to 2 weeks
4–8 weeks
4–8 weeks
4–8 weeks
4–8 weeks
8–12 weeks
Efficacy and safety of Hibiscus sabdariffa in cardiometabolic health: An overview of reviews and updated dose-response meta-analysis.
Complementary therapies in medicine (2025) · Meta analysis
Overview of systematic reviews and updated dose-response meta-analysis confirms cardiometabolic benefits of Hibiscus sabdariffa
A systematic review and meta-analysis of the effects of Hibiscus sabdariffa on blood pressure and cardiometabolic markers.
Nutrition reviews (2022) · Meta analysis
Hibiscus significantly reduced systolic BP by −7.10 mmHg (95%CI −13.00 to −1.20) versus placebo
Efficacy of Hibiscus sabdariffa on Reducing Blood Pressure in Patients With Mild-to-Moderate Hypertension: A Systematic Review and Meta-Analysis of Published Randomized Controlled Trials.
Journal of cardiovascular pharmacology (2022) · Meta analysis
13 RCTs (1205 participants) analyzed; hibiscus significantly reduced SBP by −6.67 mmHg and DBP by −4.35 mmHg vs placebo
Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer's disease.
CNS Neuroscience & Therapeutics (2014) · Systematic review
Multiple clinical trials demonstrated improvements in memory and attention in healthy young adults following acute and chronic Salvia officinalis or Salvia lavandulaefolia administration.
Exploring the therapeutic impact of Salvia officinalis on lipid and oxidative stress markers in patients with polycystic ovary syndrome - a randomized placebo-controlled clinical trial.
BMC Complementary Medicine and Therapies (2025) · Rct · n=60
Women with PCOS receiving Salvia officinalis extract showed significant reductions in total cholesterol, LDL cholesterol, and triglycerides compared to the placebo group.
Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease
J Clin Pharm Ther (2003) · Rct · n=42
Significant improvement in ADAS-cog and CDR-SB scores vs placebo (P<0.003)
Based on multiple RCTs showing improvements in word recall, working memory, and attention. Effects varied by specific cognitive domain and population. Most studies used standardized extracts.
AI-estimated from published studies. Interpret as directional guidance.
Hibiscus has a higher evidence score (5.6/10 vs 7.8/10) and wins in 2 of 3 categories.
For reduce inflammation, Sage has a higher relevance score (60 vs 32).
No known interactions between Hibiscus and Sage have been documented in our database. However, always consult a healthcare provider before combining supplements.